Skip to main content
. Author manuscript; available in PMC: 2010 Jun 22.
Published in final edited form as: Am J Transplant. 2010 Mar 26;10(5):1210–1220. doi: 10.1111/j.1600-6143.2010.03089.x

Figure 1. BALB/c cardiac allograft survival in CD27−/− and wild-type (WT) B6 recipients.

Figure 1

(A) Both CD27−/− (n = 5) and WT recipients (n = 5) rejected allografts at a similar tempo. (B) Depletion of CD4+ cells in both CD27−/− (n = 5) and WT recipients (n = 5) significantly prolonged allograft survival, but there was no difference in allograft survival between the two groups. (C) Depletion of CD8+ cells had no effect on allograft survival in both CD27−/− (n = 5) and WT recipients (n = 5).